BlackRock Fund Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$41.2M	Buy	2,977,143 +508,684	+21%	+$8.16M	0.01%	1804
2016 Q3	$44.6M	Buy	2,468,459 +124,460	+5%	+$2M	0.01%	1658
2016 Q2	$33.6M	Buy	2,343,999 +21,886	+0.9%	+$297K	0.01%	1741
2016 Q1	$27.7M	Buy	2,322,113 +129,969	+6%	+$1.36M	0.01%	1797
2015 Q4	$29.2M	Sell	2,192,144 -242,905	-10%	-$2.99M	0.01%	1814
2015 Q3	$26.2M	Buy	2,435,049 +141,530	+6%	+$1.55M	0.01%	1826
2015 Q2	$18.5M	Buy	2,293,519 +83,948	+4%	+$617K	﹤0.01%	2159
2015 Q1	$14.6M	Buy	2,209,571 +441,495	+25%	+$3.01M	﹤0.01%	2234
2014 Q4	$11.3M	Buy	1,768,076 +169,339	+11%	+$1.37M	﹤0.01%	2390
2014 Q3	$15.8M	Buy	1,598,737 +9,645	+0.6%	+$103K	﹤0.01%	2097
2014 Q2	$17.9M	Sell	1,589,092 -136,556	-8%	-$1.47M	0.01%	2095
2014 Q1	$20.9M	Buy	1,725,648 +65,246	+4%	+$834K	0.01%	1973
2013 Q4	$20.9M	Buy	1,660,402 +11,480	+0.7%	+$183K	0.01%	1970
2013 Q3	$27.5M	Buy	1,648,922 +205,486	+14%	+$3.45M	0.01%	1756
2013 Q2	$21.9M	Buy	+1,443,436	New	+$21.9M	0.01%	1799